Medicine & TechnologyGenoskin recently developed ex vivo skin models from natural human skin donated by patients who undergo surgery to replace animal models and predict clinical results.
A short, free-to-play online game where players learn how political misinformation is made and spread has shown to make its players more resistant to political misinformation.
The U.K. National Health Service is setting all its systems ready to administer COVID-19 vaccines before Christmas, if any of the 200 vaccine candidates become available.
Around this time last year, the small company of Novavax was on the verge of closing down. Today, they are one of the world's leading developers of the coronavirus vaccine.
With AstraZeneca's vaccine trials resuming worldwide, results have shown good immune responses in young and older adults alike. However, trials are yet to resume in the United States as volunteers await their second dose.
Over 80,000 new coronavirus cases were reported in a single day this week in the United States. Experts fear that despite promises of an available vaccine within months, the winter season may be the worst season of the pandemic. Dr. Fauci also proposes that wearing face masks should be mandated.
China is already in the middle of their post-Covid new normal as if the pandemic is already gone. Currently, several companies have made their vaccine candidates available to anyone upon payment.
China joins COVAX and commits to providing several developing countries with millions of vaccine doses. The four leading vaccine candidates from China are for the global public good.
A new method of gene therapy involves minimally invasive microneedles. The patch includes genetic material within nanoparticles and can be applied for various clinical uses such as cancers, diseases, and vaccines.
As vaccines candidates are being developed to cure coronavirus, some developers use squalene - an ingredient found in shark liver oil. Wildlife experts fear that millions of sharks may be killed if vaccine developers don't look for alternative sources.